Phytopharm Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Oxford United Kingdom (1995)
Status: Acquired by Ixico (2013)

Organization Overview

First Clinical Trial
2004
NCT00130429
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree